The Addisons Disease Treatment Market is expected to grow at a CAGR of 6.27% from 2026 to 2034, with market revenue increasing from US$ 819.88 million in 2025 to US$ 1,416.84 million by 2034. The market is gaining momentum as awareness of adrenal insufficiency improves, diagnosis becomes more accessible, and demand for long-term hormone replacement therapies continues to...

Brain Tumor Therapeutic Market Technology Innovations and Future Outlook The Brain Tumor Therapeutic Market Technology landscape is evolving rapidly, driven by innovations in targeted therapy, immunotherapy, and drug delivery systems. MRFR research indicates that pharmaceutical companies are increasingly leveraging advanced technologies to improve therapeutic efficacy, reduce side effects, and...

The global personalized medicine market was valued at USD 567.1 billion in 2024. It is projected to reach USD 656.5 billion in 2026 and USD 1,196.2 billion by 2033, expanding at a CAGR of 8.8% from 2025 to 2033. North America represented the largest regional market in 2024, accounting for 40.2% of global revenue. Asia Pacific is expected to register the fastest growth over the forecast period....

The global DNA repair drugs market is witnessing significant growth as advancements in precision medicine, genomic research, and targeted cancer therapies continue to reshape the healthcare industry. According to industry analysis, the global DNA repair drugs market was valued at US$ 5.9 Bn in 2022 and is projected to surpass US$ 10.4 Bn by the end of 2031, expanding at a CAGR of 6.5% from 2023...

The global drug discovery outsourcing market is experiencing robust growth as pharmaceutical and biotechnology companies increasingly rely on external expertise to accelerate innovation and reduce operational costs. Valued at US$ 3.6 billion in 2022, the market is projected to surpass US$ 7.5 billion by 2031, expanding at a CAGR of 7.8% during the forecast period. This growth is driven by...

  The homeopathy market trends reflect broader shifts in healthcare delivery, consumer expectations, and technological capabilities that are fundamentally transforming how homeopathic products are developed, marketed, and delivered to end users. Digital transformation stands at the forefront of these trends, with telemedicine platforms enabling remote consultations with homeopathic...

The modern healthcare landscape is witnessing a significant pivot from the traditional "one-size-fits-all" pharmaceutical model toward highly personalized therapeutic interventions. At the heart of this transformation is the compounding sector, which provides tailored medication solutions for patients whose needs are not met by mass-produced drugs. A comprehensive Compounded Pharmacy Market...

The management of spinal inflammatory diseases is undergoing a radical shift as the Axial Spondyloarthritis Market Technology sector integrates artificial intelligence and advanced biomarkers in 2026. For decades, the primary hurdle in this field was the "diagnostic gap"—the years-long delay between symptom onset and clinical confirmation. Today, the introduction of AI-driven MRI analysis...

The global cancer profiling market is witnessing remarkable growth as healthcare systems increasingly embrace precision medicine and advanced diagnostic technologies. Valued at US$ 13.4 billion in 2022, the market is projected to expand at a CAGR of 10.3% from 2023 to 2031, surpassing US$ 31.4 billion by the end of the forecast period. The growing prevalence of cancer worldwide, rising...

Hyper Personalized Medicine Market Forecast to Reach USD 8,027.67 billion by 2034 Polaris Market Research reports that the hyper personalized medicine market was valued at USD 2,859.84 billion in 2025 and is estimated at USD 3,201.55 billion in 2026. The market is projected to reach USD 8,027.67 billion by 2034, with a 12.2% compound annual growth rate during 2026–2034. The assessment...

Polaris Market Research announces the release of its latest research report Hyper Personalized Medicine Market. The newly published report captures all the key forces influencing market transformation. As industries evolve amid technological shifts, economic disruptions, and regulatory changes, the study outlines how the market is responding and where it is headed. Designed to serve...

While oncological applications historically dominated molecular diagnostic research, there is a substantial, highly critical expansion occurring within the fields of cardiovascular health and complex metabolic disorders. Lifestyle modifications, dietary transitions, and extended lifespans have driven an increase in chronic ischemic heart disease, heart failure, and complex type-2 diabetes cases...

The cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...

The global personalized medicine market was valued at USD 567.1 billion in 2024. It is projected to reach USD 656.5 billion in 2026 and USD 1,196.2 billion by 2033, expanding at a CAGR of 8.8% from 2025 to 2033. North America represented the largest regional market in 2024, accounting for 40.2% of global revenue. Asia Pacific is expected to register the fastest growth over the forecast period....

The personalized medicine market was valued at USD 567.1 billion in 2024 and is estimated to reach USD 656.5 billion in 2026. By 2033, the market is projected to reach USD 1,196.2 billion, expanding at a CAGR of 8.8% from 2025 to 2033. Advances in genomic testing, targeted therapeutics, health data analytics, and customized wellness solutions are contributing to this growth. Download a free...

The animal drug compounding market is gaining importance as veterinarians increasingly require customized therapies for animals whose needs cannot be adequately addressed by standardized commercial medicines. Compounding allows formulations to be adjusted for dosage, strength, delivery method, flavor, and species-specific requirements. The market was valued at USD 1.7 billion in 2025 and is...